University of Alabama at Birmingham
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Alabama at Birmingham sits in the top decile of US sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count).
University of Alabama at Birmingham: 1,160 sponsored US clinical trials, 216 recruiting.
University of Alabama at Birmingham sponsors 1,160 registered US clinical trials on ClinicalTrials.gov, 216 of them currently recruiting, and 723 completed. 97 of these trials are in Phase 3-4 (later-stage) and 259 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
University of Alabama at Birmingham ranks in the top decile of sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
723 of 812 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,160 total, page 18 of 24
Race Adiposity Interactions Regulate Mechanisms Determining Insulin Sensitivity
NCT03043235
Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture
NCT01878383
Glutamate, Brain Connectivity and Duration of Untreated Psychosis
NCT02034253
Vitamin D Supplementation in Older Adults With Urinary Incontinence
NCT01971801
Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis
NCT01969409
Dyslipidemia and Diabetic Retinopathy
NCT03403283
Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus
NCT02319525
EUS-FNA With and Without Suction
NCT02072915
Effectiveness of Perineural Clonidine as an Adjuvant With Ropivacaine for Popliteal Nerve Block in Patients Undergoing Foot and Ankle Surgery
NCT01986751
Integrating ENGagement and Adherence Goals Upon Entry iENGAGE to Control HIV
NCT01900236
Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of COPD
NCT03110614
Effects of Vitamin D Replacement on Hormones Regulating Iron Metabolism in Individuals With Chronic Kidney Disease
NCT01988116
CPB Versus Sham Treatment for Pain Management in Small Duct Chronic Pancreatitis
NCT02054910
Effect of Resistance Training on Musculoskeletal Endocrine Interactions
NCT02040727
Fludarabine / Total Body Irradiation Regimen for ALLO HCT in Acute Lymphoblastic Leukemia
NCT01991457
Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis
NCT02065154
A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care
NCT01907269
ENABLE: CHF-PC (Comprehensive Heartcare For Patients and Caregivers)
NCT03177447
Telehealth-Education-Based Program for Military Caregivers of Injured Service Members With Head Injuries
NCT02215187
Early Gestational Diabetes Screening in the Gravid Obese Woman
NCT01864564
Machines Assisting Recovery From Stroke
NCT02787694
ARCH Research Protocol for Provider Alcohol Pharmacotherapy Training and Assessment
NCT02610517
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
NCT01767792
Effect of Antioxidant Vitamins on Coagulopathy and Nosocomial Pneumonia After Severe Trauma
NCT01897792
Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection
NCT01602614
The Benefits of a Preoperative Anemia Management Program
NCT01888003
Mediators of Kidney-Bone Communication in Childhood
NCT02040740
Pressure Ulcer Healing With Microcyn
NCT02001558
Heart Rate Response to Regadenoson and Sudden Cardiac Death
NCT01842035
High Intensity Interval Versus Continuous Moderate Intensity Training: Maximizing the Benefits of Exercise in Overweight Adolescents
NCT01935323
Obesity and Endogenous Oxalate Synthesis
NCT03808090
Virtual Gout Clinic
NCT02790463
Bone Augmentation Techniques in Extraction Sockets
NCT01836783
LRRK2 and Other Novel Exosome Proteins in Parkinson's Disease
NCT01860118
The Effect of Low Frequency STN DBS on Sleep and Vigilance in Parkinson's Disease (PD) Patients
NCT01769690
Vitamin D Receptor Polymorphisms and Non-Melanoma Skin Cancer Risk
NCT03040492
Virtual Walking for Neuropathic Pain in Spinal Cord Injury
NCT01884662
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
NCT01767779
Improving Energy Balance in Men With Prostate Cancer
NCT01886677
The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma
NCT01673802
Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors
NCT01492582
Vitamin D Supplementation for Extremely Preterm Infants
NCT01600430
A Placebo-controlled Trial of Daliresp on Chronic Obstructive Pulmonary Disease (COPD)
NCT01572948
Promoting Weight-Loss in African American Cancer Survivors in the Deep South
NCT03150381
Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation
NCT01690143
Treatment of Suicidal Ideation With Intravenous Ketamine Infusion
NCT01887990
Advanced Glycation End-products, Inflammation and Vascular Health in Chronic Kidney Disease
NCT01769963
Effect of Postop Steroids on Cardiovascular/Respiratory Function in Neonates Undergoing Cardiopulmonary Bypass
NCT01595386
Fracture and Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART)
NCT01591252
Evaluation of Complication Rates Using Filter vs. Centrifuge and Heparin vs. Citrate Anticoagulation
NCT04351438
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 129 |
| Phase 2 | 130 |
| Phase 3 | 25 |
| Phase 4 | 72 |
Therapeutic Areas
What is open in the University of Alabama at Birmingham pipeline
216 recruiting of 1,160 indexed (19% open); 723 completed (62%).
Phase mix: 97 late (III/IV) vs 259 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Alabama at Birmingham: open-pipeline peers nationwide
Peers matched on 1,160 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Alabama at Birmingham sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,160 trials (± recruiting share)
- NYU Langone Health · 1,164 trials · 17% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Minnesota · 19% recruiting · 966 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Alabama at Birmingham page
1,160 registered trials is a research-attention snapshot, not an endorsement of University of Alabama at Birmingham or any single study.
- 216 of University of Alabama at Birmingham's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Alabama at Birmingham studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Alabama at Birmingham pipeline card: 1,160 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.